Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group (Q74038855)
Jump to navigation
Jump to search
scientific article published on 01 January 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group |
scientific article published on 01 January 1998 |
Statements
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group (English)
Vincenti F
Kirkman R
Light S
Bumgardner G
Pescovitz M
Neylan J
Wilkinson A
Ekberg H
Gaston R
Backman L
1 January 1998